RDNT

$61.49-1.15 (-1.84%)

Market ClosedAs of Mar 20, 8:00 PM UTC

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$61.49
Potential Upside
5%
Whystock Fair Value$64.56
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryDiagnostics & Research

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.77B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-1.71%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.76

Recent News

MarketBeat
Mar 22, 2026

RadNet CFO Touts “Unprecedented” Volume Momentum, Sees Digital Health as 2026 Growth Engine

RadNet (NASDAQ:RDNT) CFO Mark Stolper told attendees at KeyBanc’s Healthcare Forum that the company exited 2025 with what he described as “unprecedented” momentum in imaging volumes, while its digital health business continued to scale and is expected to be a major growth driver in 2026. In a firesi

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 18, 2026

Why RadNet (RDNT) Shares Are Sliding Today

Shares of diagnostic imaging company RadNet (NASDAQ:RDNT) fell 2.8% in the afternoon session after the company outlined strong growth plans and expressed confidence during an investor conference.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 17, 2026

3 Russell 2000 Stocks That Concern Us

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 15, 2026

How Investors Are Reacting To RadNet (RDNT) 2026 AI-Driven Revenue And EBITDA Growth Targets

RadNet, Inc. recently presented at the Barclays 28th Annual Global Healthcare Conference, where CFO Mark Stolper outlined expectations for 2026 revenue growth of 17%–19% and EBITDA growth of 18%–22% driven by advanced imaging and AI-enabled solutions. Despite reporting full-year 2025 revenue of US$2.04 billion alongside a net loss of US$18.65 million, the company is emphasizing AI-enabled imaging and workflow improvements as key levers for improving profitability and strengthening its...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 13, 2026

Why RadNet (RDNT) Stock Is Up Today

Shares of diagnostic imaging company RadNet (NASDAQ:RDNT) jumped 3.4% in the afternoon session after the company presented a robust strategic outlook at the Barclays 28th Annual Global Healthcare Conference, projecting strong growth for 2026.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.